Electroretinographic Effects of an Intravitreal Injection of Triamcinolone in Rabbit Retina | Ophthalmology | JAMA Ophthalmology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.238.77. Please contact the publisher to request reinstatement.
1.
Jonas  JDegenring  R Intravitreal injection of crystalline triamcinolone acetonide in the treatment of diffuse diabetic macular edema [in German].  Klin Monatsbl Augenheilkd 2002;219429- 432PubMedGoogle ScholarCrossref
2.
Jonas  JBKreissig  ISofker  ADegenring  RF Intravitreal injection of triamcinolone for diffuse diabetic macular edema.  Arch Ophthalmol 2003;12157- 61PubMedGoogle ScholarCrossref
3.
Martidis  ADuker  JSGreenberg  PB  et al.  Intravitreal triamcinolone for refractory diabetic macular edema.  Ophthalmology 2002;109920- 927PubMedGoogle ScholarCrossref
4.
Massin  PAudren  FHaouchine  B  et al.  Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.  Ophthalmology 2004;111218- 225PubMedGoogle ScholarCrossref
5.
Al-Haddad  CEJurdi  FABashshur  ZF Intravitreal triamcinolone acetonide for the management of diabetic papillopathy.  Am J Ophthalmol 2004;1371151- 1153PubMedGoogle ScholarCrossref
6.
Karacorlu  MOzdemir  HKaracorlu  SAlacali  NMudun  BBurumcek  E Intravitreal triamcinolone as a primary therapy in diabetic macular oedema.  Eye 2005;19382- 386PubMedGoogle ScholarCrossref
7.
Challa  JGillies  MPenfold  PGyory  JHunyor  ABillson  F Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.  Aust N Z J Ophthalmol 1998;26277- 281PubMedGoogle ScholarCrossref
8.
Danis  RCiulla  TPratt  LAnliker  W Intravitreal triamcinolone acetonide in exudative age-related macular degeneration.  Retina 2000;20244- 250PubMedGoogle ScholarCrossref
9.
Jonas  JBAkkoyun  IBudde  WMKreissig  IDegenring  RF Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.  Arch Ophthalmol 2004;122218- 222PubMedGoogle ScholarCrossref
10.
Jonas  JBDegenring  RFKreissig  IFriedemann  TAkkoyun  I Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide: a prospective comparative nonrandomized study.  Eye 2005;19163- 170PubMedGoogle ScholarCrossref
11.
Jonas  JBKreissig  IHugger  PSauder  GPanda-Jonas  SDegenring  R Intravitreal triamcinolone acetonide for exudative age related macular degeneration.  Br J Ophthalmol 2003;87462- 468PubMedGoogle ScholarCrossref
12.
Ip  MS Intravitreal injection of triamcinolone: an emerging treatment for diabetic macular edema.  Diabetes Care 2004;271794- 1797PubMedGoogle ScholarCrossref
13.
McCuen  BWBessler  MTano  YChandler  DMachemer  R The lack of toxicity of intravitreally administered triamcinolone acetonide.  Am J Ophthalmol 1981;91785- 788PubMedGoogle Scholar
14.
Tano  YChandler  DMachemer  R Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide.  Am J Ophthalmol 1980;90810- 816PubMedGoogle Scholar
15.
Hida  TChandler  DArena  JEMachemer  R Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations.  Am J Ophthalmol 1986;101190- 195PubMedGoogle Scholar
16.
Roth  DChieh  JSpirn  MGreen  SYarian  DChaudhry  N Noninfectious endophthalmitis associated with intravitreal triamcinolone injection.  Arch Ophthalmol 2003;1211279- 1282PubMedGoogle ScholarCrossref
17.
Nelson  MTennant  MSivalingam  ARegillo  CBelmont  JMartidis  A Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection.  Retina 2003;23686- 691PubMedGoogle ScholarCrossref
18.
Bakri  SJShah  AFalk  NSBeer  PM Intravitreal preservative-free triamcinolone acetonide for the treatment of macular oedema.  Eye 2005;19686- 688PubMedGoogle ScholarCrossref
19.
Ciardella  APKlancnik  JSchiff  WBarile  GLangton  KChang  S Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study.  Br J Ophthalmol 2004;881131- 1136PubMedGoogle ScholarCrossref
20.
Wenzel  AGrimm  CSeeliger  MW  et al.  Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor.  Invest Ophthalmol Vis Sci 2001;421653- 1659PubMedGoogle Scholar
21.
Zemel  ELoewenstein  ALei  BLazar  MPerlman  I Ocular pigmentation protects the rabbit retina from gentamicin-induced toxicity.  Invest Ophthalmol Vis Sci 1995;361875- 1884PubMedGoogle Scholar
22.
Lei  BPerlman  I The contributions of voltage- and time-dependent potassium conductances to the electroretinogram in rabbits.  Vis Neurosci 1999;16743- 754PubMedGoogle ScholarCrossref
23.
Bush  RALei  BTao  W  et al.  Encapsulated cell-based intraocular delivery of ciliary neurotrophic factor in normal rabbit: dose-dependent effects on ERG and retinal histology.  Invest Ophthalmol Vis Sci 2004;452420- 2430PubMedGoogle ScholarCrossref
24.
Jamison  JABush  RALei  BSieving  PA Characterization of the rod photoresponse isolated from the dark-adapted primate ERG.  Vis Neurosci 2001;18445- 455PubMedGoogle ScholarCrossref
25.
Kong  JGouras  P The effect of body temperature on the murine electroretinogram.  Doc Ophthalmol 2003;106239- 242PubMedGoogle ScholarCrossref
26.
Mizota  AAdachi-Usami  E Effect of body temperature on electroretinogram of mice.  Invest Ophthalmol Vis Sci 2002;433754- 3757PubMedGoogle Scholar
27.
Rufiange  MDumont  MLachapelle  P Correlating retinal function with melatonin secretion in subjects with an early or late circadian phase.  Invest Ophthalmol Vis Sci 2002;432491- 2499PubMedGoogle Scholar
28.
Birch  DGBerson  ELSandberg  MA Diurnal rhythm in the human rod ERG.  Invest Ophthalmol Vis Sci 1984;25236- 238PubMedGoogle Scholar
29.
Bush  RASieving  PA A proximal retinal component in the primate photopic ERG a-wave.  Invest Ophthalmol Vis Sci 1994;35635- 645PubMedGoogle Scholar
30.
Newell  SWHainsworth  DPSanford  DAshton  P Clearance and metabolism of intravitreal triamcinolone [ARVO abstract].  J. Invest Ophthalmol Vis Sci 1993;34 ((suppl)) 1425Google Scholar
31.
Stockton  RASlaughter  MM B-wave of the electroretinogram: a reflection of ON bipolar cell activity.  J Gen Physiol 1989;93101- 122PubMedGoogle ScholarCrossref
32.
Hood  DCBirch  DG The a-wave of the human electroretinogram and rod receptor function.  Invest Ophthalmol Vis Sci 1990;312070- 2081PubMedGoogle Scholar
33.
Lei  B The ERG of guinea pig (Cavis porcellus): comparison with I-type monkey and E-type rat.  Doc Ophthalmol 2003;106243- 249PubMedGoogle ScholarCrossref
Laboratory Sciences
November 1, 2005

Electroretinographic Effects of an Intravitreal Injection of Triamcinolone in Rabbit Retina

Author Affiliations

Author Affiliations: Mason Eye Institute (Drs Dierks, Lei, and Hainsworth) and Department of Veterinary Medicine and Surgery, College of Veterinary Medicine (Dr Lei and Mrs Zhang), University of Missouri–Columbia.

Arch Ophthalmol. 2005;123(11):1563-1569. doi:10.1001/archopht.123.11.1563
Abstract

Objective  To investigate the clinical, histologic, and electroretinographic effects of intravitreal injection of triamcinolone acetonide suspension in the rabbit retina.

Methods  Three groups of 6 rabbits each received intravitreal injections. Group 1 received 4 mg of triamcinolone acetonide, group 2 received an equal volume (0.1 mL) of the corticosteroid supernatant, and group 3 received 4 mg of triamcinolone acetonide with the supernatant replaced with balanced salt solution. Uninjected left eyes served as controls. Electroretinograms were obtained at baseline and at 3 to 4 and 6 to 7 days after injection of triamcinolone. Enucleated eyes were examined histologically.

Results  Ocular examination revealed no differences among the 3 groups. When subjected to stimulation with moderate to high flash intensities, eyes that had received intravitreal injections of triamcinolone (groups 1 and 3) had a 10% to 25% increase in dark-adapted a- and b-wave electroretinographic amplitudes. No histologic differences were observed between injected and control eyes.

Conclusions  Intravitreal injection of 4 mg of triamcinolone acetonide does not cause a toxic reaction in the rabbit retina after 7 days. Triamcinolone therapy may augment the rod-driven electroretinographic responses, suggesting a mechanism by which visual function may improve.

Clinical Relevance  Evaluation of the toxic effects of triamcinolone is useful because of increased applications of intravitreal injection.

×